The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Update Your SMART Union Mobile App Today!
- San Carlos School Bus Operators ratify substantial wage and 401(k) increases
- Local 94 Leads by Example
- Truth and Lies about the BNSF Crew Consist Agreement
- Monopoly in the Making: Union Pacific’s Merger Ambitions Could Shake UP the Rail Industry
- Celebrating the Life and Legacy of Brother Daniel A. May
- Championing Rail and Transit Safety from Coast to Coast
- Potential NJ Transit Strike: What SMART-TD Members Need to Know
- Union Support Available for Members Affected by Maryland, Virginia, and Pennsylvania Flooding
- Local 202’s Tierney Gallegos connects union strength with public good